Purdue Pharma, the maker of OxyContin, has been granted an 18-day extension to negotiate a comprehensive settlement for its opioid litigation. This comes after the Supreme Court rejected a previous plan that would have shielded the Sackler family from lawsuits. The extension allows Purdue to modify its approach and potentially salvage parts of the original settlement.
The Supreme Court has rejected a nationwide settlement between Purdue Pharma, the maker of OxyContin, and state and local governments, effectively shielding the Sackler family from lawsuits related to the opioid epidemic. This decision, which came after a 5-4 vote, has significant implications for victims and the fight against opioid addiction.
